Deep Track Capital, LP

Position in BEAM — Beam Therapeutics Inc.

CIK 1856083 GREENWICH, CT

Position in BEAM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$34,320,000

+$14,761,171 QoQ

Shares Held

1,000,000

+21.8% QoQ

Ownership

0.968%

of shares outstanding

% of Portfolio

0.52%

of 13F equity value

Holder Rank

#23

of 274 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. BEAM ranks #36 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IMVT	Immunovant, Inc.	9,341,151	$359,914,548
2	GPCR	Structure Therapeutics Inc.	4,740,072	$254,399,664
3	PCVX	Vaxcyte, Inc.	4,300,000	$249,959,000
4	ALNY	Alnylam Pharmaceuticals, Inc.	825,000	$248,349,750
5	MANE	Veradermics, Inc	2,000,000	$245,880,000
6	TARS	Tarsus Pharmaceuticals, Inc.	3,666,768	$230,786,377
7	OCUL	Ocular Therapeutix, Inc	19,686,282	$193,319,289
8	BMRN	Biomarin Pharmaceutical Inc	3,307,481	$189,254,062

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$34,320,000	1,000,000	+21.8%	Shares	Sole	2026-08-14
2026-03-31	$19,558,829	820,765	+159.9%	Shares	Sole	2026-05-15
2025-03-31	$6,166,890	315,765	-68.9%	Shares	Sole	2025-05-15
2023-09-30	$24,426,166	1,015,641	-22.9%	Shares	Sole	2023-11-14
2023-06-30	$42,061,899	1,317,316	+5.4%	Shares	Sole	2023-09-06
2023-03-31	$38,275,000	1,250,000	+7.2%	Shares	Sole	2023-05-15
2022-12-31	$45,620,759	1,166,473	+16.6%	Shares	Sole	2023-02-14
2022-09-30	$47,640,000	1,000,000	-20.0%	Shares	Sole	2022-11-14
2022-06-30	$48,387,500	1,250,000	+63.7%	Shares	Sole	2022-08-12
2022-03-31	$43,762,875	763,750	+9.1%	Shares	Sole	2022-05-16
2021-12-31	$55,783,000	700,000	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.